Quorum Review IRB Announces Updated OnQ Web Portal
Seattle, WA
Quorum Review IRB introduced a new version of the secure OnQ™ portal. The OnQ ™ portal is a powerful information hub providing sponsors, CROs, and investigators immediate access to all Board correspondence and site start-up status information and also allows clients to submit new studies online. The OnQ™ portal now offers sorting and searching capability, making it a valuable tool for clients.
Quorum’s upgraded OnQ™ portal features an enhanced site status report that provides information on the status of site submissions, virtually real-time. In addition, the portal offers access to all Board correspondence, now in a sortable and searchable format for easy retrieval of study documents.
The portal also features a library of helpful resources, including a searchable version of Quorum’s Handbook that allows researchers to find information about Quorum policies and guidelines quickly and easily.
The upgrades to the OnQ™ portal were made with the needs of research organizations in mind, and many were the direct result of feedback that Quorum has received from portal users.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
